Want to see AU:AN1 full AI Analyst Report?
AN1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Improved Cash FlowImproved cash flow from restructuring indicates better financial management, enhancing the company's ability to fund operations and growth.
Strong Brand PerformanceStrong brand performance, especially in Bouf Haircare, suggests robust market demand and potential for revenue growth.
Regained Control Over IPRegaining control over Midkine IP allows Anagenics to independently commercialize and potentially expand its product offerings.
Bears Say
Persistent LossesPersistent losses and cash burn indicate financial instability, challenging the company's ability to sustain operations without external funding.
Revenue DeclineA significant revenue decline undermines growth prospects and pressures the company to stabilize its financial performance.
Negative Cash FlowConsistently negative cash flow highlights reliance on external funding, posing risks to financial independence and long-term viability.
Anagenics News
AN1 FAQ
What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Anagenics Limited’s market cap is AU$5.91M.
When is Anagenics Limited’s upcoming earnings report date?
Anagenics Limited’s upcoming earnings report date is Sep 02, 2026 which is in 46 days.
How were Anagenics Limited’s earnings last quarter?
Anagenics Limited released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.
Is Anagenics Limited overvalued?
According to Wall Street analysts Anagenics Limited’s price is currently Overvalued.
Does Anagenics Limited pay dividends?
Anagenics Limited does not currently pay dividends.
What is Anagenics Limited’s EPS estimate?
Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anagenics Limited have?
Anagenics Limited has 985,450,800 shares outstanding.
What happened to Anagenics Limited’s price movement after its last earnings report?
Anagenics Limited reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Anagenics Limited?
Currently, no hedge funds are holding shares in AU:AN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Anagenics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:AN1 Sentiment 67%
Sector Average 63%
Sector Average 63%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-31.48%
Trailing 12-Months
Asset Growth
-4.93%
Trailing 12-Months
Company Description
Anagenics Limited
Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
EVE Health Group Limited
―
Skin Elements Limited
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Hydration Pharmaceuticals Co. Ltd.
―